 |
afatinib |
|---|---|
| Trade Name | Gilotrif |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2012-12-03 00:00:00 |
| Sponsor | Boehringer Ingelheim Pharmaceuticals, Inc.;P. O. Box 368, 900 Ridgebury Road;Ridgefield, Connecticut, 06877 |
Related Access Program